ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Century Therapeutics
This role leads the day-to-day execution of Type 1 diabetes cell therapy clinical studies from start-up through close-out. The position involves coordinating endocrinology, transplant, and specialty-site activities to support treatment readiness and high-quality study conduct. The successful candidate will oversee operational planning, procedural workflows, and serve as a key cross-functional partner across clinical development and operations teams.
Century Therapeutics is a biotechnology company building an allogeneic, iPSC-derived cell therapy platform targeting autoimmune diseases, including type 1 diabetes, and cancer. The company leverages the self-renewing capacity of induced pluripotent stem cells (iPSCs) combined with advanced cellular engineering and manufacturing technologies to develop fit-for-purpose cell therapies. Century is listed on NASDAQ under the ticker IPSC and is headquartered in Philadelphia.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Century Therapeutics.